flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 VisualAbstract: Improves in Patients with Type 2 Diabetes and Chronic Disease In the FLOW trial, researchers
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13


























